Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics,Immunology
Reference24 articles.
1. Pallesen J, Wang N, Corbett KS, Wrapp D, Kirchdoerfer RN, Turner HL, et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci USA. 2017;114:E7348–E57.
2. Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. The New England J Med. 2020;383:2439–50.
3. World Health Organization (September 2020). “Messenger RNA encoding the full-length SARS-CoV-2 spike glycoprotein”. WHO MedNet.Archived from the original document on 5 January 2021. Retrieved 16 December 2020..
4. Sahin U, Kariko K, Tureci O. mRNA-based therapeutics-developing a new class of drugs. Nat Rev Drug Discov. 2014;13:759–80.
5. Sibbald B. Death but one unintended consequence of gene-therapy trial. CMAJ. 2001;164:1612.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献